Internet Domain Name Expansion Pushes Dispute Resolution Cases Up At WIPO 18/03/2016 by Catherine Saez, Intellectual Property Watch 5 Comments The World Intellectual Property Organization has released data on disputes between trademark owners and third parties who are registering new domain names with the original brand name. Disputes are on the rise and the proportion relating to new generic top-level domain names is growing, it found. Fashion and banking are the prominent areas for disputes.
US Congress Hearing All Positive On IANA Transition Process 17/03/2016 by Monika Ermert for Intellectual Property Watch 2 Comments Witnesses testifying at the United States House Communications and Technology Subcommittee today unanimously reported success of the multistakeholder preparations for the transition of oversight over the Internet Assigned Numbers Authority (IANA) from the US government to the multistakeholder internet community.
Another Big Turnout For Second Public Dialogue Of UN High-Level Panel On Medicines Access 17/03/2016 by William New and Catherine Saez, Intellectual Property Watch Leave a Comment Today in Johannesburg, South Africa, the second of two public dialogues was held by the United Nations Secretary General’s High-Level Panel on Access to Medicines, drawing another packed room and many ideas, experiences and suggestions for solutions.
Asia On The Heels Of US And Europe In Patent Applications At WIPO; Developing Countries Lagging 16/03/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment China, Japan and South Korea are among the top five countries filing international patent applications at the World Intellectual Property Organization, while the United States continues to lead in patent and trademark applications. Far behind, developing countries seem to be having a hard time catching up.
US Officials Under Pressure To Include Industry In IP Talks With India 16/03/2016 by Intellectual Property Watch 2 Comments The United States government has increasingly engaged India on intellectual property rights and other trade issues in recent years, and US negotiators are under still more pressure to include industry in this engagement and deliver more results, a recent letter from 14 members of the US Congress shows.
Obama Administration’s Draft Source Code Policy Requires Free Software 16/03/2016 by Intellectual Property Watch 2 Comments The Obama administration last week published a draft software source code policy that requires all government agencies to publish their custom-build software as free software for public use, according to the Free Software Foundation Europe (FSFE).
Ukraine To Amend Customs Code, Ratify Amendments To TRIPS 16/03/2016 by Jaroslaw Adamowski for Intellectual Property Watch 1 Comment The Ukrainian Parliament is currently drafting an amended Customs Code to introduce a number of changes to the country’s intellectual property legislation. Moreover, in mid-March, local lawmakers authorised Ukraine’s President Petro Poroshenko to ratify the protocol amending the TRIPS agreement which enables increased exports of pharmaceuticals produced under compulsory licences to countries which are not capable of manufacturing them locally.
UNESCO Report On Globalisation Of Cultural Trade 15/03/2016 by Intellectual Property Watch 1 Comment A new UN report provides significant detail on the increasing flows of cultural trade worldwide. On intellectual property rights, the report appears to primarily examine copyright as a form of revenue generation.
Changes At Top Of The UN; Recruitment Ongoing 15/03/2016 by Catherine Saez, Intellectual Property Watch 1 Comment This year will be the last in office for United Nations Secretary General Ban Ki-moon. A number of Eastern European candidates are being proposed by their governments to be the next secretary general. The UN Framework Convention on Climate Change, as well as the UN Environment Programme are expected to have a new head by summer. Meanwhile, chairs are actively revolving in law offices.
China’s Pharmaceutical Sector And The IP Puzzle 15/03/2016 by Intellectual Property Watch Leave a Comment Despite impressive growth, the pharmaceutical sector in China still relies on generic drug production since the majority of domestic companies cannot compete with country-based foreign corporations. Currently, following WTO pressure to oblige China to comply with IP regulations, more and more patented drugs are entering the market. Unfortunately, in spite of a newly introduced IP friendly bill, a puzzling situation persists, writes Pietro Dionisio.